Amaranth

Amaranth Medical is a medical device company focused on the development of next-generation bioresorbable scaffolds for the treatment of cardiovascular and peripheral vascular diseases. The company's proprietary technology platform utilizes a high-molecular-weight polymer to create scaffolds that provide the mechanical strength and radial support of traditional metallic stents while being fully absorbed by the body over time. This approach aims to restore the natural vasomotion of the treated vessel and reduce the risk of long-term complications associated with permanent implants. Amaranth's clinical pipeline includes the MAGNITUDE, FORTITUDE, and APTITUDE scaffolds, which have been evaluated in clinical trials for patients with symptomatic coronary artery disease.